Approval process for generic drugs will likely be suspended to a 12-month
Published: 2007-08-29 07:00:00
Updated: 2007-08-29 07:00:00
Korea will set up a system to suspend the approval process of a generic drug when the original U.S. developer files a complaint about patent violation against a generic maker that applies for product approval, according to an official at the Korea Food and Drug Administration.
In a phone call ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
